v3.25.2
Commitments and Contingencies - Additional Information (Details)
€ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
May 16, 2022
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2022
USD ($)
Jan. 31, 2022
USD ($)
Jul. 31, 2019
USD ($)
Dec. 31, 2014
USD ($)
LicensedProduct
Jan. 31, 2014
USD ($)
Sep. 30, 2013
USD ($)
Jul. 31, 2011
USD ($)
Nov. 30, 2009
EUR (€)
Jun. 30, 2025
USD ($)
OperatingLease
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
OperatingLease
Jun. 30, 2024
USD ($)
Lessee Lease Description [Line Items]                            
Estimated payments due                     $ 26,020,000   $ 26,020,000  
Operating lease liabilities                     18,112,000   18,112,000  
Research and development expenses                     $ 22,882,000 $ 16,879,000 46,225,000 $ 33,932,000
National Institute of Health                            
Lessee Lease Description [Line Items]                            
License issue royalty fee               $ 100,000            
Sales milestone payments               600,000            
Development and regulatory milestone payments               $ 700,000            
Patent licensing reimbursement fees                         30,000.00  
Royalty Bearing Patent License Agreement                            
Lessee Lease Description [Line Items]                            
License agreement term                   10 years        
Royalty Bearing Patent License Agreement | IND Filings                            
Lessee Lease Description [Line Items]                            
Potential milestone payments | €                   € 10        
Clearside                            
Lessee Lease Description [Line Items]                            
Expenses                         0 0
Upfront payment         $ 100,000                  
Royalties on net sales         20.00%                  
License agreement expiration period         10 years                  
Clearside | Maximum                            
Lessee Lease Description [Line Items]                            
Aggregate milestones payment         $ 21,000,000                  
LI-COR, Inc. | 2014 Exclusive Agreement                            
Lessee Lease Description [Line Items]                            
One-time upfront license issuance fee             $ 100,000              
Research and development expenses                         0 0
License agreement expiration period             10 years              
LI-COR, Inc. | 2014 Exclusive Agreement | Maximum                            
Lessee Lease Description [Line Items]                            
Aggregate milestone payments             $ 200,000              
LI-COR, Inc. | 2014 Non- Exclusive Agreement                            
Lessee Lease Description [Line Items]                            
License issue fee           $ 30,000.00                
Milestone payments                         0 0
LI-COR, Inc. | 2014 Non- Exclusive Agreement | Maximum                            
Lessee Lease Description [Line Items]                            
Payments for development and commercial milestones           $ 400,000                
Life Technologies                            
Lessee Lease Description [Line Items]                            
Number of licensed products | LicensedProduct           5                
Initial license fee           $ 100,000                
Initial license fee for first licensed product     $ 400,000                      
Initial license fee for additional licensed product     500,000                      
Payment for sublicense     200,000                      
Payment for use of cell line document package     30,000.00                      
Annual development fee           100,000                
Non-refundable, Non- creditable fee           300,000                
Change of control fees     $ 500,000     200,000                
One time perpetual license agreement fee       $ 50,000.00                    
Expenses                         0 0
Expense related to agreement including sublicense                         0 0
Dr. John Schiller | 2014 Non- Exclusive Agreement                            
Lessee Lease Description [Line Items]                            
Required amendment payment   $ 60,000.00                        
Required amendment payment due period   30 days                        
Dr. John Schiller | Collaboration Research and Development Agreement                            
Lessee Lease Description [Line Items]                            
Annual development fee                 $ 30,000.00          
Agreement term                 2 years          
First payment due                 30 days          
Subsequent payments due                 30 days          
Research collaboration fees                         $ 0 $ 0
Dr. John Schiller | Collaboration Research and Development Agreement | 10th Anniversary                            
Lessee Lease Description [Line Items]                            
Required amendment payment   $ 50,000.00                        
Required amendment payment due period   30 days                        
Rakuten | 2014 Non- Exclusive Agreement                            
Lessee Lease Description [Line Items]                            
License issue fee           30,000.00                
Rakuten | 2014 Non- Exclusive Agreement | Maximum                            
Lessee Lease Description [Line Items]                            
License issue fee           $ 300,000                
Office and Laboratory Facility                            
Lessee Lease Description [Line Items]                            
Number of operating lease | OperatingLease                     1   1  
Estimated payments due $ 35,200,000                          
Lease commencement date Aug. 01, 2022                          
Operating lease, option to extend term 7 years                          
Letters of credit $ 800,000                          
Maximum reimbursement cost $ 500,000                          
Incurred of expenses related to expansion                         $ 500,000